|Boston Scientific Corporation||$27.17||2.59%|
|Cardiovascular Systems Inc.||$22.37||2.03%|
|Edwards Lifesciences Corp.||$135.56||1.41%|
|Johnson and Johnson||$132.03||-0.84%|
|Merit Medical Systems, Inc.||$46.65||2.08%|
|The Medicines Company||$31.03||-6.44%|
Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.